Biotech

All Articles

Ionis axes eye condition coming from targets of Roche-partnered possibility after information disappoint

.One More of Ionis Pharmaceuticals' vital midphase readouts has fallen short of assumptions, motivat...

Biogen's CEO claimed no high-risk handle 2023. He prepares to be daring

.While Biogen's pharma peers are actually hunting for late-stage properties along with little risk, ...

Instil refills pipe in $2B biobucks deal with ImmunOnco

.Instil Bio has been actually a biotech in search of a pipe after it ditched its own lead properties...

Biogen bows out Denali Alzheimer's collab

.Biogen has handed back rights to an early Alzheimer's ailment system to Denali Therapies, going out...

Takeda faucets brand new mind people oncology company-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of considerable management hirings, shootings as...

Vertex, hammered by AATD once again, goes down 2 assets on discard heap

.Vertex's try to alleviate a rare genetic condition has actually reached yet another drawback. The b...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of team

.Vir Medical's second-quarter profits record wasn't except big headlines. The business invited a tri...

Galapagos stops briefly CAR-T cell treatment litigation over Parkinsonism case

.Galapagos has actually paused application in a test of a BCMA-directed CAR-T tissue treatment, pump...

James Wilson leaving Penn to release pair of new biotechs

.After greater than three decades, gene treatment pioneer James Wilson M.D., Ph.D., is leaving the C...

3 biotechs make an effort to beat the summertime warmth through dropping workers

.As biotechs attempt to transform a new page in August, a minimum of 3 firms have dropped personnel ...